Absci to participate in upcoming investor conferences

Vancouver, wash. and new york, aug. 20, 2025 (globe newswire) -- absci corporation (nasdaq: absi), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics with generative ai, today announced the company will be participating in the following upcoming investor conferences:

ABSI Ratings Summary

ABSI Quant Ranking